| Cat. No. |
Product Name |
Information |
| PC-73137 |
Asundexian
FXIa inhibitor
|
Asundexian (BAY 2433334) is a highly potent, selective and orally active inhibitor of Factor XIa (FXIa) with IC50 of 0.92 nM. |
| PC-60957 |
LY-517717
|
A potent, selective, and orally bioavailable factor Xa (FXa) inhibitor for prevention and treatment of thromboembolic diseases.. |
| PC-60956 |
Razaxaban hydrochloride
FXa inhibitor
|
Razaxaban hydrochloride (DPC906, BMS561389) highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM, >5,000-fold selectivity over a series of related serine proteases. |
| PC-60955 |
Razaxaban
FXa inhibitor
|
Razaxaban (DPC906, BMS561389) is a highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM, >5,000-fold selectivity over a series of related serine proteases. |
| PC-45832 |
Apixaban
FXa inhibitor
|
Apixaban (BMS-562247) is a highly potent, selective, efficacious, and orally bioavailable inhibitor of factor Xa (FXa) with Ki of 0.08 nM. |
| PC-45897 |
Rivaroxaban
FXa inhibitor
|
Rivaroxaban (BAY 59-7939) is a highly potent and selective, direct FXa inhibitor with IC50 of 0.7 nM. |
| PC-73462 |
Milvexian
Factor XIa inhibitor
|
Milvexian (BMS-986177, JNJ-70033093) is a highly potent, reversible, orally bioavailable factor XIa (FXIa) inhibitor with Ki of 0.11 and 0.38 nM for human and rabbit FXIa, respectively. |
| PC-72148 |
ZED3197
FXIIIa inhibitor
|
ZED3197 (ZED-3197) is a novel peptidomimetic direct-acting, potent and selective inhibitor of human FXIIIa, inhibits human plasma derived FXIII‐A2B2 and the recombinant cellular form (FXIII‐A2) with IC50 of 10 and 14 nM, respectively. |
| PC-35604 |
Zifaxaban
|
Zifaxaban is a novel, potent, selective, direct and oral factor Xa inhibitor with IC50 of 11.1 nM (human FXa), displays > 10,000-fold selectivity than other serine proteases. |
| PC-63565 |
BMS-654457
|
BMS-654457 is a potent, reversible and direct inhibitor of factor XIa (FXa) with Ki of 0.4 nM. |
| PC-63359 |
Letaxaban
|
Letaxaban (TAK-442, TAK442) is a potent, selective and direct factor Xa (FXa) inhibitor with Ki of 1.8 nM for hFXa, >440-fold selectivity than thrombin and negligible effects on trypsin, plasmin, and tPA. |
| PC-62006 |
BMS-962212
|
BMS-962212 is a potent, highly selective and reversible small molecule coagulation Factor XIa (FXIa) inhibitor with Ki of 0.7 nM. |
